Original release date:
May 5, 2022
Access to this course expires on: March 23, 2025 at 11:59 PM Pacific Time
CME 5.25
Course Description
The 2003 SARS coronavirus outbreak, the 2009 H1N1 influenza pandemic, the 2014-15 Ebola outbreak in West Africa, and the current SARS-CoV2 pandemic remind us that emerging infectious agents do not need passports to cross international borders. Every day, there are unnoticed infectious agents that cross from one country to another. For example, respiratory viruses pass from person to person in invisible air particles and can travel around the world within hours, or international travelers may return home with a bacterial or fungal infection acquired abroad for which all available antibiotics are resistant. Infectious agents also pass from one species to another, and thus animal and human health are closely linked. Climate change allows the spread of infectious agents to areas where they did not exist or where they may have been eradicated, and expansion of human populations into natural areas increases the risk of exposure to zoonotic pathogens. This session will explore the interactions of environmental, veterinary and human health as they impact infectious disease pathology through the world. Different agents and global emergencies will be presented to demonstrate the impact of infectious diseases in our practices. Some sessions include a Q&A at the end of the lecture presentation.
Target Audience
Practicing academic and community pathologists, and pathologists-in-training
Learning Objectives
Upon completion of this educational activity, learners will be able to:
Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 5.25
AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.
The following faculty reported relevant financial relationships: Michael Mina, MD, PhD: Employee, eMed
The following faculty reported no relevant financial relationships: Daniel J. Diekema, MD, Cynthia E. Flynn, MD, Gillian L. Hale, MD, MPH, Alvaro C. Laga Canales, MD, MMSC, Fernando J. Torres-Velez, DVM, PhD
The Education Committee members reported financial relationships:
Kimberly Allison: Advisory Board Member, Mammotome
Jennifer Gordetsky: Consultant, Jansen
Liron Pantanowitz: Consultant, Hamamatsu; Advisory Board Member, Ibex, Stock Ownership, LeanAP Innovators
David Schaeffer: Consultant, Alimentiv Inc., Pfizer, Merck, Diaceutics, Stock Ownership, Satisfai Health Inc.
Lynette Sholl: Grant or Research Support, Genentech, Consultant, Genentech, EMD Serono, Stock Ownership, Moderna
The following Education Committee members reported no relevant financial relationships: Adebowale Adeniran, Laura Collins, Sarah Dry, Carla Ellis, William Faquin, Yuri Fedoriw, Karen Fritchie, Kristin Jensen, Levon Katsakhyan, Melinda Lerwill, M. Beatriz Lopes, Julia Naso, Carlos Parra-Herran, Rajiv Patel, Charles Quick, Olga Weinberg, Ilan Weinreb, Maria Westerhoff, Rhonda Yantiss
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME credit, all learners must complete the evaluation. View and print your certificate by
clicking here.
Buy the entire Long Course and get a great discount! Not A Member? Click Here